STOCKHOLM, SWEDEN / ACCESSWIRE / November 24, 2021 / iZafe Group (STO:IZAFE-B)
Stockholm, Sweden, iZafe Group AB (publ) ('iZafe' or 'the Company') announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with its third quarter report. The report will be available to the public on November 29, 2021 at 08:30 (8:30 a.m.) CET.
Questions will be answered by Chief Executive Officer Anders Segerström and published on December 8, 2021 on iZafe Group's investor site under the heading Financial Reports, Investor Questions.
Please send your questions to firstname.lastname@example.org before 10:00 (10 a.m.) CET on December 1, 2021.
Carl-Fredrik Bothén, Chief Marketing Officer
Phone number: +46 73-064 48 67
Anders Segerström, Chief Executive Officer
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
Södra Fiskartorpsvägen 20
114 33 Stockholm
iZafe Group is a Swedish Life-Science company that develops and markets medical and digital security solutions to create safer drug handling at home. The company's digital medication dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. The products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life. Customers today consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe Group sells primarily through well-established partners who already have long and deep customer relationships with the priority customer groups. The head office is located in Stockholm.
The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: email@example.com . Further information is available at www.izafe.se/investor-relations/ .
SOURCE: iZafe Group
View source version on accesswire.com: